2022. Glucose, urea, and creatinine laboratory tests in people starting antiretroviral therapy with dolutegravir or efavirenz: a cohort study in Belo Horizonte, Brazil. Research, Society and Development. 11, 5 (Apr. 2022), e43711528541. DOI:https://doi.org/10.33448/rsd-v11i5.28541.